Takeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience Post author:Sam Post published:December 13, 2017 Post category:BioPharma As part of the licence agreement, Takeda has taken a strategic equity stake in Izana. Source: BioSpace You Might Also Like <b>SerImmune</b> Raises $8M To Map The Human Antibody Repertoire June 19, 2017 Juno, Thermo Fisher Ink CAR T Manufacturing Partnership December 19, 2017 NIH Hooks Up With 11 Top Biopharmas for $215 Million Cancer Moonshot Deal October 12, 2017
